2017

Sahin U, Derhovanessian E, Miller M, Kloke BP, Simon P, Löwer M, Bukur V, Tadmor AD, Luxemburger U, Schrörs B, Omokoko T, Vormehr M, Albrecht C, Paruzynski A, Kuhn AN, Buck J, Heesch S, Schreeb KH, Müller F, Ortseifer I, Vogler I, Godehardt E, Attig S, Rae R, Breitkreuz A, Tolliver C, Suchan M, Martic G, Hohberger A, Sorn P, Diekmann J, Ciesla J, Waksmann O, Kemmer-Brück A, Witt M, Zillgen M, Rothermel A, Kasemann B, Langer D, Bolte S, Diken M, Kreiter S, Nemecek R, Gebhardt C, Grabbe S, Höller C, Utikal J, Huber C, Loquai C, Türeci Ö: Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature 2017/07/05/online.
DOI; PubMed

Show abstract

Stadler CR, Bahr-Mahmud H, Celik L, Hebich B, Roth AS, Roth RP, Kariko K, Tureci O, Sahin U: Elimination of large tumors in mice by mRNA-encoded bispecific antibodies. Nat Med. 2017/06/12/online.
DOI; PubMed

Show abstract

Hassel JC, Flossdorf M, Hänzelmann S, Winkler J, Roth J, Lauenstein C, Appel L, Streit E, Halama N, Faryna M, Enk A, Offringa R, Sahin U, Poschke I: Investigation of the immune infiltrate of melanoma metastases under immune checkpoint inhibition. J Clin Oncol. 35, no. 15_suppl (May 2017) 9570-9570.
DOI;

Show abstract

Diken M, Vormehr M, Grunwitz C, Kreiter S, Türeci Ö, Sahin U: Discovery and Subtyping of Neo-Epitope Specific T-Cell Responses for Cancer Immunotherapy: Addressing the Mutanome.Methods Mol Biol.2017;1499:223-236.
DOI; PubMed

Show abstract

Hinz T, Kallen K, Britten CM, Flamion B, Granzer U, Hoos A, Huber C, Khleif S, Kreiter S, Rammensee HG, Sahin U, Singh-Jasuja H, Türeci Ö, Kalinke U: The European Regulatory Environment of RNA-Based Vaccines. Methods Mol Biol. 2017;1499:203-222.
DOI; PubMed

Show abstract

Diken M, Kranz LM, Kreiter S, Sahin U: mRNA: A Versatile Molecule for Cancer Vaccines. Curr Issues Mol Biol. 2017;22:113-128
DOI; PubMed

Show abstract